Combined treatment with gemcitabine plus oxaliplatin shows encouraging efficacy in patients with relapsed or cisplatin-refractory germ cell tumours

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1430, 2004-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

By Varuni Kondagunta G.   Bacik Jennifer   Schwartz Lawrence   Sheinfeld Joel   Bajorin Dean   Vuky Jacqueline   Marion Stephanie   Mazumdar Madhu   Bosl George J.   Motzer Robert J.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC

By  

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

By Feldman Darren   Turkula Stefan   Ginsberg Michelle   Ishill Nicole   Patil Sujata   Carousso Maryann   Bosl George   Motzer Robert  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 523-528

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus cisplatin for NSCLC

By  

Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

New prospects for the treatment of germ-cell tumours

By Droz J-P.   Culine S.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. : 1139-1157

Informa Healthcare

Access to resources Recommend Favorite